- Pharmaceutical companies
- Santen Pharmaceutical
Santen Pharmaceutical
Phone: +81 81663217000
Fax: 81-6-6321-5082
Native name | 参天製薬株式会社 |
---|---|
Type | Public KK |
Traded as | TYO: 4536 OSE: 4536 |
Industry | Pharmaceutical |
Founded | Osaka, Japan (1890 (1890)) |
Founder | Kenkichi Taguchi |
Headquarters | Grand Front Osaka Tower A, 4-20 Ofuka-cho, Kita-ku, Osaka 530-8552, Japan |
Key people | Akira Kurokawa, (CEO and President) |
Products |
|
Revenue | $ 2.429 billion (FY 2018) (¥ 243.0 billion) (FY 2018) |
Net income | $ 175.661 million (FY 2012) (¥ 16.521 billion) (FY 2012) |
Number of employees | 3,805(consolidated) (as of March 31, 2018) |
Website | Official website |
As a specialized pharmaceutical company, Santen continues to make utmost efforts to contribute to ophthalmic treatment around the world.
For detailed contact information visit location pages below.
Santen Pharmaceutical's locations around the world
Europe
North America
Clinical Trials sponsored by Santen Pharmaceutical
-
Santen Pharmaceutical Co., Ltd.WervingOpenhoekglaucoom, oculaire hypertensieJapan
-
Santen Pharmaceutical Co., Ltd.Voltooid
-
Santen Pharmaceutical Co., Ltd.Voltooid
-
Santen Pharmaceutical Co., Ltd.VoltooidPrimair openhoekglaucoom | Oculaire hypertensieJapan
-
Santen Pharmaceutical Co., Ltd.Voltooid
-
Santen Pharmaceutical Co., Ltd.Voltooid
-
Santen Pharmaceutical Co., Ltd.VoltooidAllergische conjunctivitisJapan
-
Santen Pharmaceutical Co., Ltd.Voltooid
-
Santen Pharmaceutical Co., Ltd.VoltooidOculaire hypertensie | OpenkamerhoekglaucoomJapan
-
Santen Pharmaceutical Co., Ltd.VoltooidPrimair openhoekglaucoom, oculaire hypertensieJapan